SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2020-05-21 18:33
Tx date 2020-05-20
$EXE
Extendicare Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,510.40
+800 vol
$5.64 each
4,000
Filed 2020-04-02 16:38
Tx date 2020-03-30
$ASP
Acerus Pharmaceuticals Corporation
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$104,645.77
+2,315,172 vol
$0.0452 each
2,915,172
Filed 2020-03-06 23:18
Tx date 2020-03-02
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Deferred Share Unit
56 - Grant of rights

+7,251 vol
19,888
Filed 2020-03-06 23:16
Tx date 2020-03-02
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+13,466 vol
75,165
Filed 2020-02-03 19:35
Tx date 2019-12-31
$EXE
Extendicare Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Rights - Deferred Share Units
56 - Grant of rights

+4,721 vol
4,721
Filed 2020-02-03 19:34
Tx date 2019-05-30
$EXE
Extendicare Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Rights - Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-13 17:27
Tx date 2019-12-09
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-33,000
-10,000 vol
$3.30 each
34,421
Filed 2019-09-13 17:40
Tx date 2019-09-10
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Deferred Share Unit
56 - Grant of rights

+6,637 vol
12,637
Filed 2019-09-13 17:40
Tx date 2019-09-10
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+26,699 vol
61,699
Filed 2019-08-09 15:01
Tx date 2019-08-08
$ASP
Acerus Pharmaceuticals Corporation
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,860
+40,500 vol
$0.12 each
129,000
Filed 2019-07-17 16:40
Tx date 2019-04-22
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-100,256
-8,320 vol
$12.05 each
44,421
Filed 2019-06-03 11:17
Tx date 2019-05-30
$EXE
Extendicare Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
3,200
Filed 2019-03-07
Tx date 2019-03-06
$ASP
Acerus Pharmaceuticals Corporation
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$26,000
+200,000 vol
$0.13 each
600,000
Filed 2019-01-31
Tx date 2019-01-28
$QPT
Quest PharmaTech Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-01-31
Tx date 2019-01-29
$QPT
Quest PharmaTech Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$27,000
+150,000 vol
$0.18 each
150,000
Filed 2019-01-31
Tx date 2019-01-28
$QPT
Quest PharmaTech Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-12-28
Tx date 2018-12-27
$ASP
Acerus Pharmaceuticals Corporation
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,135
+28,500 vol
$0.11 each
88,500
Filed 2018-12-05
Tx date 2018-07-25
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-12-05
Tx date 2018-11-30
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Deferred Share Unit
56 - Grant of rights
$45,060
+6,000 vol
$7.51 each
6,000
Filed 2018-12-05
Tx date 2018-07-25
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2018-12-05
Tx date 2018-11-30
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$262,850
+35,000 vol
$7.51 each
35,000
Filed 2018-08-28
Tx date 2018-08-28
$ASP
Acerus Pharmaceuticals Corporation
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,600
+20,000 vol
$0.28 each
60,000
Filed 2018-07-26
Tx date 2018-07-25
$ACB
Aurora Cannabis Inc.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
52,741
Filed 2018-07-07
Tx date 2018-06-29
$LEAF
MedReleaf Corp.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Deferred Share Unit (DSU)
56 - Grant of rights
$140,004.65
+5,119 vol
$27.35 each
15,645
Filed 2018-03-26
Tx date 2018-03-23
$ASP
Acerus Pharmaceuticals Corporation
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
400,000
Filed 2018-03-21
Tx date 2017-03-10
$ASP
Acerus Pharmaceuticals Corporation
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
300,000
Filed 2017-06-13
Tx date 2017-06-07
$LEAF
MedReleaf Corp.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Deferred Share Unit (DSU)
00 - Opening Balance-Initial SEDI Report
10,526
Filed 2017-06-09
Tx date 2017-06-08
$LEAF
MedReleaf Corp.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$22,204
+2,600 vol
$8.54 each
2,600
Filed 2017-06-08
Tx date 2017-06-07
$LEAF
MedReleaf Corp.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-08
Tx date 2017-06-07
$LEAF
MedReleaf Corp.
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-04
Tx date 2016-11-04
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,550
+15,000 vol
$0.17 each
40,000
Filed 2016-08-12
Tx date 2016-08-11
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,250
+25,000 vol
$0.09 each
25,000
Filed 2016-08-12
Tx date 2015-06-26
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-08
Tx date 2015-06-26
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-08
Tx date 2016-03-04
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
100,000